PTC Therapeutics
$63.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$63.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.38 (+0.60%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell PTCT and other stocks, options, and ETFs commission-free!
About PTCT
PTC Therapeutics, Inc. Common Stock, also called PTC Therapeutics, is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ. The listed name for PTCT is PTC Therapeutics, Inc. Common Stock.
CEO
Stuart W. Peltz
Employees
761
Headquarters
South Plainfield, New Jersey
Founded
1998
Market Cap
4.34B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
363.45K
High Today
$64.50
Low Today
$63.22
Open Price
$63.49
Volume
318.05K
52 Week High
$64.62
52 Week Low
$30.79
Collections
Analyst Ratings
64%
of 11 ratings
Buy
64%
Hold
36%
Sell
0%
PTCT Earnings
-$2.62
-$1.75
-$0.87
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 1, After Hours